NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fulcrum Therapeutics, Inc. ("Fulcrum Therapeutics, Inc.") (NASDAQ:FULC) concerning possible violations of federal securities laws. Fulcrum announced on September 12, 2024, that "its Phase 3 REACH trial evaluating losmapimod in patients with FSHD, did […]

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elastic N.V. ("Elastic N.V.") (NYSE:ESTC) concerning possible violations of federal securities laws. Elastic announced on August 30, 2024, that it was reducing its revenue forecast for the year, a move that prompted a

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biomea Fusion, Inc. ("Biomea Fusion, Inc.") (NASDAQ:BMEA) concerning possible violations of federal securities laws. Biomea issued a press release on June 6, 2024, announcing that it "has received notice from the U.S. Food

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Temenos AG ("Temenos AG") (OTC PINK:TMSNY) concerning possible violations of federal securities laws. On February 15, 2024, securities analyst Hindenburg Research published a research report titled Temenos: Major Accounting Irregularities, Failed Products and

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of JFrog Ltd. ("JFrog") (NASDAQ:FROG) concerning possible violations of federal securities laws. JFrog reported financial results on August 7, 2024, for its second quarter ended June 30, 2024, and lowered its guidance for fiscal

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of MaxLinear, Inc. ("MaxLinear") (NASDAQ:MXL) concerning possible violations of federal securities laws. On July 24, 2024, after the market closed, MaxLinear announced earnings results for its second quarter of 2024 and that net revenue

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for

Company will host earnings call on Thursday, November 14, 2024 COLUMBIA, MD / ACCESSWIRE / October 14, 2024 / Rekor Systems, Inc. (NASDAQ:REKR) ("Rekor "or the" Company "), a leader in developing and implementing state-of-the-art roadway intelligence technology, today announced that its financial results for the third quarter of 2024 will be released on Thursday,

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Dollar General Corporation ("Dollar General Corporation") (NYSE:DG) concerning possible violations of federal securities laws. Dollar General lowered its outlook for same-store sales and earnings per share on August 29, 2024. According to CNBC,